Pharmaceutical Information |
Drug Name |
Choline magnesium trisalicylate |
Drug ID |
BADD_D00456 |
Description |
Choline magnesium trisalicylate is a non-acetylated salicylate used widely as a nonsteroidal anti-inflammatory drug. Trisalicylate significantly reduces methotrexate renal clearance, displacing methotrexate from protein, increasing the fraction unbound by 28% [A19653, A19654]. |
Indications and Usage |
Choline magnesium trisalicylate is used to reduce pain and inflammation caused by conditions such as arthritis. This medication is also used to treat fever in adults. |
Marketing Status |
approved |
ATC Code |
Not Available |
DrugBank ID |
DB01401
|
KEGG ID |
D07694
|
MeSH ID |
C017959
|
PubChem ID |
54682045
|
TTD Drug ID |
Not Available
|
NDC Product Code |
Not Available |
UNII |
DJJ95FJP1H
|
Synonyms |
choline magnesium trisalicylate | Tricosal | Tegunor | Trilisate |
|
Chemical Information |
Molecular Formula |
C26H29MgNO10 |
CAS Registry Number |
85169-11-5 |
SMILES |
C[N+](C)(C)CCO.C1=CC=C(C(=C1)C(=O)O)[O-].C1=CC=C(C(=C1)C(=O)O)[O-].C1=CC=C(C(=C1
)C(=O)O)[O-].[Mg+2] |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|